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Broadband (550–1350 nm) diffuse 
optical characterization of thyroid 
chromophores
Sanathana Konugolu Venkata Sekar  1, Andrea Farina2, Alberto Dalla Mora1, Claus Lindner  3, 
Marco Pagliazzi3, Mireia Mora4,5, Gloria Aranda4,5, Hamid Dehghani6, Turgut Durduran3,7, 
Paola Taroni1,2 & Antonio Pifferi1,2
Thyroid plays an important role in the endocrine system of the human body. Its characterization by 
diffuse optics can open new path ways in the non-invasive diagnosis of thyroid pathologies. Yet, the 
absorption spectra of tyrosine and thyroglobulin–key tissue constituents specific to the thyroid organ–
in the visible to near infrared range are not fully available. Here, we present the optical characterization 
of tyrosine (powder), thyroglobulin (granular form) and iodine (aqueous solution) using a time domain 
broadband diffuse optical spectrometer in the 550–1350 nm range. Various systematic errors caused 
by physics of photo migration and sample inherent properties were effectively suppressed by means 
of advanced time domain diffuse optical methods. A brief comparison with various other known tissue 
constituents is presented, which reveals key spectral regions for the quantification of the thyroid 
absorbers in an in vivo scenario.
Thyroid hormone secretion plays a crucial role in the endocrine functions of the human body. Thyroid nodules 
are a common occurrence and recent studies have revealed that the incidence of thyroid cancer is rapidly increas-
ing in modern society1. The study of thyroid nodular pathology is of great interest in the field of endocrinology 
given its high prevalence: palpable nodules are around 5%, but their prevalence reaches about 19–76% after cer-
vical ultrasound2. Although the risk of malignancy is low (less than 5–10% of nodules)3, the high prevalence of 
these nodules requires a careful study to rule out malignancy. This study consists of performing a thyroid ultra-
sound and a fine needle aspiration biopsy (FNAB) of the nodule when appropriate. Ultrasound characteristics 
of the nodules can help us to distinguish between a benign and a malignant lesion. However, few features are 
specific of malignancy. Moreover, FNAB, that is a minimally invasive approach that can cause pain and discom-
fort, may have problems with sensitivity and specificity, with a 25% false negative and a 10% false positive rates4. 
These limitations lead to the search of complementary techniques to improve the specificity and, also, to exploit 
non-invasive methods to diagnose thyroid pathologies in order to reduce unnecessary invasive procedures.
In literature, various optical techniques have been explored to diagnose thyroid related pathologies, such as 
diffuse optical spectroscopy5,6, diffuse correlation spectroscopy5, static and time-resolved fluorescence spectros-
copy7,8, optical biopsy using Raman spectroscopy9,10, Fourier transform infrared spectroscopy11, optical coher-
ence tomography12, elastic light-scattering spectroscopy13 and two-photon excited fluorescence spectroscopy14. 
Among these techniques, diffuse optical approaches are non-invasive in nature and have the capability to investi-
gate both chemical and functional properties of the organ. In recent decades, diffuse optics has been successfully 
applied to various human in vivo tissue studies: optical mammography15,16, tissue diagnosis17, optical biopsy of 
bone18, skin cancer diagnosis19, brain hemodynamics monitoring20 are few examples. Importantly, diffuse optics 
quantifies tissue constituents such as lipid, water, collagen, melanin, oxy- and deoxy-hemoglobin, by fitting the 
measured in vivo spectra to a library of tissue constituent spectra, which could be correlated to physiological and 
pathological conditions of the organ under study.
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The diffuse optical study of thyroid is still in its nascent stage. Our previous work, Lindner et al.5, showed 
interesting variations in the hemodynamics of the healthy and nodular thyroid tissue, thus opening further inter-
ests in the diffuse optical community. However, this study–due to the limited number of wavelengths–considered 
only oxy- and deoxy-hemoglobin, neglecting the other tissue constituents that are specific to the thyroid organ 
and may have significant contribution in the near-infrared. This, in turn, may have caused some systematic arti-
facts in the absolute quantification, and may also imply that potential biomarkers that are accessible to the tech-
nique are not exploited.
To address these limitations, we have studied the thyroid organ and identified three relevant absorbers to 
characterize, namely thyroglobulin, tyrosine, and iodine. Briefly, thyroid is composed by microscopic spherical 
sacs called thyroid follicles. The wall of each follicle consists mainly of follicular cells that produce two thyroid 
hormones, thyroxine or T4 and triiodothyronine or T3, which contain four or three iodine atoms, respectively. 
The colloid occupies the interior of the follicle and is formed mainly by thyroglobulin, a protein produced by the 
follicular cells that serves as a precursor for the synthesis of thyroid hormones21,22. A pictorial description of thy-
roid anatomy is shown in insets of Fig. 1. Importantly, thyroglobulin protein concentration in thyroid is relatively 
high: studies on the rat thyroid reveal it to be around 10–20%22,23.
Along with other tissue absorbers like lipid, water, collagen, oxy, deoxy- hemoglobin, considering also the spe-
cific constituents of the thyroid organ–especially thyroglobulin, tyrosine, and iodine–can lead to new resources in 
the pathological diagnosis of thyroid tissue.
To the best of our knowledge, in literature, there is the lack of thyroglobulin and tyrosine absorption spectra in 
the visible-NIR region. We have performed a preliminary work reported in reference6 and, based on the generally 
positive results obtained and critical issues identified there, we have performed the full study reported here for the 
characterization of tissue constituents. Unlike transparent samples, the highly diffusing nature and fluorescence 
of these materials in the visible region make their characterization impossible with traditional spectrophotome-
ters. A spectrometer based on an integrating sphere24 can be a good option but may fail to tackle florescence and 
the distortion of the spectrum due to the high scattering of the samples. Diffuse optical techniques can be an opti-
mal option to identify and eliminate distortion caused by scattering on the measured absorption spectrum of the 
sample25,26. In particular, time domain diffuse optics can naturally disentangle the absorption from the scattering 
coefficient25,27. Also the effect of fluorescence, the finite size of sample and the finite bandwidth of laser can be 
tackled effectively by using appropriate diffuse optical strategies28.
In this work, we present the absorption spectrum of tyrosine and thyroglobulin, in the 550–1350 and 
600–1350 nm range, respectively. We exploited time domain diffuse optical spectroscopy (TDDOS) methods 
Figure 1. Absorption and reduced scattering spectra of (a) thyroglobulin, with high absorption in the visible 
region, and (b) tyrosine, with multiple peaks over the measured window; and absorption spectrum of (c) iodine, 
rapidly decreasing upon increasing wavelength reaches asymptotically zero around 800 nm. (d) Anatomy of the 
thyroid along with images of thyroglobulin and tyrosine samples are shown in insets (top right corner).
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to address the above-mentioned challenges. A hybrid clinical time-resolved diffuse optical spectrometer29 was 
used for measuring highly scattering thyroglobulin and tyrosine samples, while iodine was characterized using a 
conventional spectrophotometer. Specific methods employed to extract absolute absorption spectra of tissue con-
stituents and the distortion caused in their absence were discussed. A brief overview and a comparison between 
characterized and already known tissue constituents is presented.
Results and Discussion
Absorption and scattering spectra of new tissue constituents. The absorption spectra of thyroglob-
ulin and tyrosine derived using the experimental approaches described in the Methods section are shown in 
Fig. 1(a,b). The spectrum of tyrosine is measured from 550–1350 nm, whereas the thyroglobulin spectrum is 
measured only from 600–1350 nm, due to its high absorption below 600 nm leading to strong signal attenuation. 
There are markedly different spectral features in the two constituent spectra. Tyrosine absorption shows six peaks 
at different wavelengths (875 nm, 915 nm, 1090 nm, 1145 nm, 1185 nm, 1290 nm) within the broadband (600–
1350 nm) window considered, while it is negligible around 800 nm. Thyroglobulin is found to have a smoothly 
decreasing absorption spectrum with a shoulder around 1000 nm followed by a major peak at 1190 nm. The 
density of thyroglobulin (granular particles) in the sample cylinder is comparatively low with respect to tyrosine 
(fine powder). In spite of its low density, thyroglobulin was found to have a higher absorption as compared to 
tyrosine, which makes it easier to detect at low concentrations. The iodine spectrum acquired through a standard 
spectrophotometer is shown in Fig. 1(c). iodine seems to contribute only in the visible region: following an expo-
nential decrease, it reaches asymptotic zero absorption around 800 nm and the absorption remains negligible up 
to 1350 nm. Overall, in comparison, the three tissue constituents exhibit different spectral features, which mini-
mize coupling between them in their quantification, thus enabling their accurate estimation in clinical studies of 
thyroid where all three coexist.
From Fig. 1(a,b), the reduced scattering spectra of thyroglobulin and tyrosine were found to be rather flat 
or only slightly decreasing with wavelength, with high mean values of 136 and 990 cm−1, respectively. A minor 
bandwidth effect due to the sharp change in the absorption spectrum of tyrosine at 1145 nm is evident in the 
form of a dip in its reduced scattering spectrum30. The fine powder form of tyrosine is reflected in its very high 
scattering coefficient.
As displayed in Fig. 1(c), the absorption of iodine decreases rapidly upon increasing wavelengths and no spec-
tral feature is observed. Povidone-iodine (PVP-I) solution, which is a chemical complex of iodine, is a transparent 
solution (i.e., with negligible scattering), and a commercial spectrophotometer was used to obtain the iodine 
spectrum. The spectrum obtained from the spectrometer was verified with the spectrum obtained by diffuse 
optics (as explained in the Methods section). We found good agreement between the spectra measured with the 
two techniques.
Challenges in the extraction of the absorption spectra. The retrieval of the absorption spectra of 
tyrosine and thyroglobulin set some challenging experimental difficulties related to scattering, fluorescence, 
boundary effects, and bandwidth effects, as detailed below.
Pure tyrosine and thyroglobulin are available in powder form, therefore standard spectrophotometer extinc-
tion spectra are severely affected by scattering contributions. A comparison between the tyrosine spectra obtained 
using a commercial spectrometer and our time domain system is shown in Fig. 2(a). Clearly, the adoption of 
the time domain scheme permitted to disentangle absorption from scattering contributions whereas the spec-
trophotometer spectrum is almost completely dominated by the very high scattering of the samples (Fig. 1(b)). 
Furthermore, to reduce the noise in the retrieved absorption spectrum, we have applied a method well described 
elsewhere31,32, which allowed us to avoid the residual coupling of the absorption and scattering coefficient due to 
the limitations of the Diffusion approximation with also improved smoothness of the spectrum. First, the absorp-
tion and scattering spectra were retrieved, as described in the Methods section, then, the scattering spectrum 
was fitted using a power law derived from Mie theory and used as a priori information in the fitting procedure to 
derive an absorption spectrum less prone to fitting instabilities.
The presence of fluorescence was observed for thyroglobulin in the visible range (600–700 nm). Fluorescence 
affects the tail of the temporal curves, reducing their slope and thereby leading to underestimated absorption 
values. This effect was eliminated by means of bandpass filters (bandwidth 10 nm). In the absence of filters, a 
relative error of 107% in absorption estimation was observed over the 600–650 nm range, as shown in Fig. 2(b). 
Additionally, as described in the Methods section, fitting was performed over different fitting ranges to under-
stand the effectiveness of filters in suppressing fluorescence photons. All fitting ranges yielded similar results, thus 
reconfirming the elimination of fluorescence effects.
In the reduced scattering spectrum of tyrosine, a slight laser bandwidth effect is observed at 1145 nm. In gen-
eral, the bandwidth effect becomes evident in diffuse optics when a large bandwidth (>5 nm) source encounters 
sharp absorption changes30, leading to a deformation of the photon temporal distribution. In practice, the cross-
talk between high absorbed and low absorbed photons due to large laser bandwidth increases with the photon 
time-of-flight, which in turn, affects the tail of the temporal curve leading to absorption underestimation. To 
effectively eliminate this perturbation, data analysis was carried out taking the spectral bandwidth of the laser 
into account at each wavelength. In this method, a weighted average of the laser bandwidth contribution was 
considered to generate theoretical light diffusion curves, which were used to fit the measured time distribu-
tions, thereby effectively nullifying the effect of the laser bandwidth on the estimated absorption spectrum30. The 
only assumption is a constant scattering coefficient over the considered laser bandwidth, which is a reasonable 
approximation considering the limited spectral range considered and the flat behavior of the reduced scattering 
spectrum. Figure 2(c) shows the distortion caused to the tyrosine peak (1145 nm) in the absence of bandwidth 
correction, displaying a relative error of 28% in the absence of correction.
www.nature.com/scientificreports/
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Boundary effects must be taken into account because of the limited sample volume, as they scale with decrease 
in scattering and size of the sample volume. Fortunately, both thyroglobulin and tyrosine exhibit very high scat-
tering and the sample holder is 25 mm in width, making measurements less prone to boundary effects. However, 
to understand the limiting point we performed simulations with optical properties (absorption and reduced scat-
tering) of thyroglobulin (more vulnerable due to lower scattering) in a sample box of different widths (3.2, 4.8, 6.4, 
10, 25 mm), which has been fitted using the semi-infinite model. It is evident from Fig. 2(d) that the absorption 
is incrementally overestimated for widths less than 10 mm. Hence, the limiting point is around 10 mm, whereas 
the sample holder used for the measurement has width of 25 mm, which is more than twice as compared to the 
limiting point, reaffirming the absence of boundary effects in the optical properties extraction.
Comparison with other tissues constituents. Though tyrosine and thyroglobulin have various inter-
esting absorption peaks, it is hard to judge on the key peak or region for their quantification, unless they are com-
pared with the other important tissue constituents. Figure 3(a) plots the new thyroid tissue constituents measured 
by our studies against already known typical tissue absorbers, namely: deoxy-hemoglobin (Hb), oxy-hemoglobin 
(HbO2), lipid, water, collagen. The concentration values for the spectra shown in Fig. 3 were obtained from mean 
values of tissue constituents in the thyroid location of reference6. Though the reference6 used homogenous model 
for constituents estimation (values contaminated by superficial tissue), it could be considered as preliminary 
values for thyroid constituents estimation. To enable easy differentiation among different tissue constituents the 
second order derivation spectra are shown in Fig. 3(b). Tyrosine has many unique features for its quantification. 
Especially, the tiny peak at 875 nm is unique to tyrosine which is evident from the derivative spectra (inset in 
Fig. 3(b)). However, its low absorption might pose challenges for its quantification. The sharp change in absorp-
tion features of tyrosine over the entire broadband region is evident from derivative spectra with maximum swing 
around 1145 nm peak. The peak around 1090 nm is interesting, as it is intense and overlaps with local minima 
of water, lipid and collagen absorption, making it an ideal location for tyrosine quantification. Though tyrosine 
has an increasing absorption around 600 nm range, high absorption dominance of Hb, HbO2, Thyroglobulin can 
make it a weak location for tyrosine detection.
In case of thyroglobulin, there is the associated risk for its coupling with collagen, due to similarities in their 
spectral features. With careful analysis, it can be seen that collagen shows peaks at 930 nm and around 1030 nm 
that are absent in the thyroglobulin spectrum. Hence, at least a point in one of these regions is needed to allow 
Figure 2. Comparison of absolution absorption spectrum with various distortion effects: (a) absorption 
features distorted by high scattering of tyrosine (red triangles), (b) fluorescence distorting the spectrum of 
thyroglobulin in the visible region (red circles), (c) Effect of finite laser bandwidth at sharp absorption change 
of tyrosine (1145 nm peak, red circles), (d) overestimation of absorption at small sample sizes (sample width: 
3.2 mm, 4.8 mm, 6.4 mm), only spectra above 10 mm sample width match with each other.
www.nature.com/scientificreports/
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distinguishability between these chromophores. Specifically, a point around 1000 nm is more beneficial, as it 
falls at the intermediate point of water and lipid peaks around 1000 nm. The steeper change in thyroglobulin 
absorption around 600 nm can also be considered as a good feature for its extraction. As it is observed from both 
Fig. 3(a,b), thyroglobulin has absorption similar to Hb and HbO2, and could be distinguished with sufficient sig-
nal to noise ratio in an in vivo scenario. Attention should be paid to avoid coupling between the similar features 
of hemoglobin spectra. However, a peak (660 nm) in the derivative spectrum of thyroglobulin is a unique feature, 
which is absent in Hb and HbO2 spectra and might thus help in avoiding coupling. The effects of other chromo-
phores, such as Cytochrome C Oxidase (CCO), elastin can be studied using this methodology in the future if 
in vivo follow-up studies reveal their signatures in the thyroid. In summary, both thyroglobulin and tyrosine have 
features distinguishable as compared to other tissue constituent spectra. Apart from the in vivo application dis-
cussed above, the spectra presented here can also be exploited for in vitro or interoperative optical characterization 
of thyroid tissue.
Conclusion
To the best of our knowledge, we have presented for the first time the absorption spectra of tyrosine and thy-
roglobulin–in powder and granular form–which are tissue constituents specific to the thyroid organ, in the 550 
to 1350 nm range. We also characterized the iodine spectrum using a standard spectrophotometer. The measure-
ments and data analysis were performed rigorously by answering various challenges posed by the highly scatter-
ing samples. The effect of fluorescence was suppressed by means of bandpass filters, which eliminated an error 
of 107% in the 600–650 nm range. A bandwidth compensation algorithm effectively made up for the effect of the 
laser bandwidth that induced 28% error on the tyrosine peak at 1145 nm. The boundary effects due to the finite 
size of the sample volume were found to be negligible adopting the geometry used in this study. Considerable 
difference is observed among the measured spectra of the thyroid constituents enabling easy distinction between 
them.
To answer the relevance of thyroid specific absorption spectra to in vivo studies, a brief comparison was pre-
sented between our newly characterized thyroid absorbers and constituents (hemoglobin, lipid, water, collagen), 
which are typical of human tissues. Importantly, key spectral regions that are significant for the in vivo detection 
of tyrosine and thyroglobulin were proposed and will be tested as the next step in our studies. The path towards 
the in vivo optical quantification of tyrosine and thyroglobulin is still an open and challenging issue. One could 
imagine that the spectral contribution could be hindered by the strong absorption of other tissue constituents 
(e.g. hemoglobin in the visible range, water in the NIR range). Also, the in vivo environment (pH, aggregation 
state) could definitely alter the absorption spectrum as compared to the one obtained here on powder samples. 
This is a topic for a further interesting investigation, which could open new opportunities for the diffuse optical 
diagnosis of thyroid related pathologies.
Methods
Time-resolved diffuse optical instrumentation. A schematic layout of the system is shown in Fig. 4. 
The system is powered by a supercontinuum pulsed fiber laser (450–1750 nm) operated at 60 MHz repetition rate. 
Wavelength tunability is achieved by the Pellin Broca prism, which couples the selected wavelength into a 50 µm 
core source fiber. Then, the laser beam is split into two parts of 95% and 5% power: the former acts as source 
to the sample, whereas the latter is the reference arm, which makes the system immune to drift and distortions 
caused by the laser and environment. The setup employs two detectors to provide high responsivity and signal to 
noise ratio over the entire measurement window (500–1350 nm): specifically, in the 500–940 nm range a Silicon 
Photomultiplier (SiPM, Excelitas Technologies, C30742-11-050-T1) and in the 940–1350 range an InGaAs pho-
tomultiplier (Hamamatsu H10330A-45). More details on the system and its validation can be found elsewhere29,33.
The broadband diffuse optical system used for this study was extensively characterized following the 
MEDPHOT Protocol34 in terms of accuracy, linearity, stability and reproducibility29. In brief, the accuracy of 
Figure 3. Comparison of thyroglobulin, tyrosine and iodine spectra with typical tissue constituent spectra 
(oxy- and deoxy-hemoglobin, lipid, water, collagen): (a) tissue constituent spectra with absorption values 
relevant to thyroid tissues6, (b) second order derivative spectra of various tissue constituents and the inset 
reveals some unique features of tyrosine spectrum.
www.nature.com/scientificreports/
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the system was validated against the well-known spectrum of water, demonstrating good agreement in the 600–
1350 nm region, spanning almost 3 decades of μa values (from 0.002 up to 1.2 cm−1). Under standard operating 
conditions (106 photon count rate, μa = 0.1 cm−1, µs’ = 10 cm−1), the noise for the absorption retrieval was found 
to be less than 2% (coefficient of variation). The stability over 10 hours and day to day reproducibility were found 
to be less than 3% and 4% (coefficient of variation), respectively.
Measurement protocol and data analysis. The L-tyrosine and thyroglobulin needed for our study were 
procured from Sigma Aldrich (part no. 93829 and T1126, respectively). L-tyrosine is a white fine powder, whereas 
thyroglobulin (extracted from porcine thyroid) is more granular with ivory complexion. More details on certifi-
cate of analysis and certificate of origin can be found on Sigma website under lot no. BCBP3212V and 018K7012V 
for tyrosine and thyroglobulin, respectively. The fine size of both samples allows effective use of diffuse optical 
techniques as it increases scattering and reduces boundary effects. For measurement, the samples were placed in 
a sample holder which is a cylinder of 25 mm diameter. The density of tyrosine (0.320 g/cm3) in the cylinder is 
comparatively higher than that of thyroglobulin (0.219 g/cm3). Measurements were performed in transmittance 
geometry with 2.2 mm and 3.2 mm thickness (source-detector separation) for tyrosine and thyroglobulin, respec-
tively. Measurements were repeated four times over 600–1350 nm at steps size of 5 nm and 10 nm, respectively, 
for tyrosine and thyroglobulin.
In case of iodine, as it is a transparent liquid, we used a standard spectrophotometer (JASCO V-570) to assess 
the spectrum over 500–1350 nm. Povidone-iodine (PVP-I) which has 10% iodine was procured from pharmacy 
(pharmaiodio). The PVP-I was diluted in water at 0.8% solid fraction and 1 cm quartz cuvette was used for the 
measurements. For comparison, PVP-I absorption was measured also using diffuse optical methods. For this 
purpose, a mixture of iodine, water and Intralipid® (to increase scattering) was made with 1% solid fraction of 
Intralipid (estimated reduced scattering coefficient 10 cm−1). The above described diffused optical spectrometer 
was exploited to retrieve the iodine spectrum from the aqueous solution of Intralipid®.
The optical properties of the samples were extracted by fitting the measured temporal curves to the solution of 
the semi-infinite slab model35 of the diffusion equation with extrapolated boundary conditions36 after convolving 
with the Instrument Response Function. The temporal curve was effectively utilized for fitting the measured 
time-resolved curves from 80% of the rising edge down to 1% of the falling edge for residual minimization.
We have found that thyroglobulin exhibits fluorescence in the visible region (600–700 nm). Thus, bandpass 
filters (BP filter) of 10 nm bandwidth were used in front of the visible range detector at these wavelengths to pre-
vent fluorescence light from entering the detector. In general, due to long decay times, fluorescence photons affect 
the tail of the temporal curves. The effectiveness of filters to eliminate fluorescence was tested by performing data 
analysis at different fitting ranges (80% to 50%, 80% to 10%, and 80% to 1%); with and without photons from the 
tail of the temporal curves. In the absence of fluorescence photos data analysis at different fitting range will yield 
same absorption and scattering spectra. The distortions caused by the finite bandwidth of the laser was eliminated 
by accounting for it in the data analysis30. The effect of boundaries on the absorption spectrum due to finite width 
of the sample cylinder was thoroughly studied to understand the limiting width of sample probe for the optical 
properties of the samples considered in this study.
Figure 4. Optical layout of time resolved diffuse optical instrumentation. The two detectors effectively cover 
the broadband range (500–1350 nm).
www.nature.com/scientificreports/
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